Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)

PHASE2CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Persistent or Permanent Non-valvular Atrial Fibrillation
Interventions
DRUG

AZD0837

ER formulation

DRUG

Aspirin

Oral form

Trial Locations (38)

Unknown

Research Site, Aalborg

Research Site, Arhus N

Research Site, Copenhagen

Research Site, Esbjerg

Research Site, Frederikssund

Research Site, Horsens

Research Site, Silkeborg

Research Site, Svendborg

Research Site, Elverum

Research Site, Gjettum

Research Site, Kongsberg

Research Site, Oslo

Research Site, Stovner

Research Site, Straume

Research Site, Bytom

Research Site, Częstochowa

Research Site, Krakow

Research Site, Lodz

Research Site, Lublin

Research Site, Ostrów Mazowiecka

Research Site, Otwock

Research Site, Płock

Research Site, Ruda Śląska

Research Site, Sopot

Research Site, Torun

Research Site, Warsaw

Research Site, Wroclaw

Research Site, Moscow

Research Site, Saint Petersburg

Research Site, Borås

Research Site, Gothenburg

Research Site, Lund

Research Site, Malmo

Research Site, Mölndal

Research Site, Stockholm

Research Site, Birmingham

Research Site, Eastbourne

Research Site, Newcastle upon Tyne

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY